E. Girodon

650 total citations
10 papers, 209 citations indexed

About

E. Girodon is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Genetics. According to data from OpenAlex, E. Girodon has authored 10 papers receiving a total of 209 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 2 papers in Epidemiology and 1 paper in Genetics. Recurrent topics in E. Girodon's work include Cystic Fibrosis Research Advances (5 papers), Neonatal Respiratory Health Research (3 papers) and Tracheal and airway disorders (3 papers). E. Girodon is often cited by papers focused on Cystic Fibrosis Research Advances (5 papers), Neonatal Respiratory Health Research (3 papers) and Tracheal and airway disorders (3 papers). E. Girodon collaborates with scholars based in France, Spain and United States. E. Girodon's co-authors include M. Goossens, N. Ghanem, Bruno Costes, Jean-Claude Soufir, Elisabeth Flori, A Jardin, Isabelle Sermet‐Gaudelus, Estelle Escudier, A. Coste and R Peynègre and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Journal of Hepatology and British Journal of Haematology.

In The Last Decade

E. Girodon

10 papers receiving 204 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. Girodon France 5 168 37 34 24 19 10 209
Nisreen Rumman United States 10 169 1.0× 19 0.5× 72 2.1× 34 1.4× 48 2.5× 23 265
M. G. Benetazzo Italy 4 196 1.2× 26 0.7× 40 1.2× 24 1.0× 12 0.6× 4 226
Robert F. Selden United States 8 76 0.5× 8 0.2× 53 1.6× 13 0.5× 20 1.1× 9 149
V Ducroz France 8 127 0.8× 26 0.7× 324 9.5× 14 0.6× 39 2.1× 12 359
D. Zemková Czechia 10 115 0.7× 11 0.3× 93 2.7× 63 2.6× 55 2.9× 20 246
Andrica de Vries Netherlands 6 26 0.2× 9 0.2× 38 1.1× 15 0.6× 7 0.4× 17 149
Surender K. Sharma India 8 51 0.3× 9 0.2× 18 0.5× 15 0.6× 9 0.5× 16 105
Benedetta Fabrizzi Italy 8 105 0.6× 12 0.3× 23 0.7× 21 0.9× 14 0.7× 20 151
Toshihiko Asahina Japan 9 147 0.9× 74 2.0× 18 0.5× 19 0.8× 9 0.5× 12 327
Deborah McCloskey United States 6 62 0.4× 10 0.3× 30 0.9× 34 1.4× 9 0.5× 6 292

Countries citing papers authored by E. Girodon

Since Specialization
Citations

This map shows the geographic impact of E. Girodon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Girodon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Girodon more than expected).

Fields of papers citing papers by E. Girodon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Girodon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Girodon. The network helps show where E. Girodon may publish in the future.

Co-authorship network of co-authors of E. Girodon

This figure shows the co-authorship network connecting the top 25 collaborators of E. Girodon. A scholar is included among the top collaborators of E. Girodon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Girodon. E. Girodon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Sermet‐Gaudelus, Isabelle, E. Girodon, F. Vermeulen, et al.. (2022). ECFS standards of care on CFTR-related disorders: Diagnostic criteria of CFTR dysfunction. Journal of Cystic Fibrosis. 21(6). 922–936. 23 indexed citations
2.
Girodon, E., Caroline Raynal, M.‐P. Audrézet, et al.. (2019). P019 Variants in the CFTR gene: a predisposition factor to aquagenic palmoplantar keratoderma. Journal of Cystic Fibrosis. 18. S62–S62. 1 indexed citations
3.
Hinzpeter, Alexandre, Cécile Zordan, Bruno Costes, et al.. (2016). 8 The importance of functional tests to assess the effect of a new CFTR variant when genotype-phenotype correlation is not possible. Journal of Cystic Fibrosis. 15. S53–S53. 1 indexed citations
4.
Girodon, E., et al.. (2008). Occurrence of CFTR de novo mutations is not so rare. Journal of Cystic Fibrosis. 7. S6–S6. 4 indexed citations
5.
Sermet‐Gaudelus, Isabelle, M Déchaux, Benoît Vallée, et al.. (2005). Chloride Transport in Nasal Ciliated Cells of Cystic Fibrosis Heterozygotes. American Journal of Respiratory and Critical Care Medicine. 171(9). 1026–1031. 32 indexed citations
6.
Dequeker, Elisabeth, E. Girodon, M. Roy Schwarz, et al.. (2004). Quality evaluation of data interpretation and reporting. Genetics in Medicine. 350–350. 1 indexed citations
7.
Coste, A., E. Girodon, V. Prulière‐Escabasse, et al.. (2004). Atypical Sinusitis in Adults Must Lead to Looking for Cystic Fibrosis and Primary Ciliary Dyskinesia. The Laryngoscope. 114(5). 839–843. 29 indexed citations
8.
Hézode, Christophe, C. Cazeneuve, I. Lonjon, et al.. (1998). Liver iron overload in patients with chronic active hepatitis C. Prevalence, role of the hemochromatosis gene and relation with hepatic histological lesions. Journal of Hepatology. 28. 110–110. 2 indexed citations
9.
Costes, Bruno, E. Girodon, N. Ghanem, et al.. (1995). Frequent Occurrence of the CFTRIntron 8 (TG)n 5T Allele in Men withCongenital Bilateral Absence of the Vas Deferens. European Journal of Human Genetics. 3(5). 285–293. 115 indexed citations
10.
Gallano, P., E. Girodon, N. Ghanem, et al.. (1992). HIGH PREVALENCE OF THE β‐THALASSAEMIA NONSENSE 37 MUTATION IN CATALONIANS FROM THE EBRO DELTA. British Journal of Haematology. 81(1). 126–127. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026